CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,506 Cr | ₹4,771 Cr | ₹4,057 Cr | ₹3,424 Cr | ₹3,446 Cr |
What is the latest Sundry Debtors ratio of CIPLA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹5,506 Cr |
| Mar2024 | ₹4,771 Cr |
| Mar2023 | ₹4,057 Cr |
| Mar2022 | ₹3,424 Cr |
| Mar2021 | ₹3,446 Cr |
How is Sundry Debtors of CIPLA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,506 Cr | 15.42 | |
| Mar2024 | ₹4,771 Cr | 17.59 | |
| Mar2023 | ₹4,057 Cr | 18.47 | |
| Mar2022 | ₹3,424 Cr | -0.62 | |
| Mar2021 | ₹3,446 Cr | - | |
Compare Sundry Debtors of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹107,506.1 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
| MANKIND PHARMA | ₹85,050.2 Cr | -1.1% | -8.2% | -17.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.9% |
-7.2% |
-9.7% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses